Tax implications for biotechs of Budget 2017

CONFLUENCE partner Colin Hailey talks through the salient points of 2017’s budget and its implications for biotechnology and technology companies. Corporation tax changes top the list…
CONFLUENCE partner Colin Hailey talks through the salient points of 2017’s budget and its implications for biotechnology and technology companies. Corporation tax changes top the list…